RE: Neal Shore, Noel W. Clarke, Andrew J Armstrong et al.Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel. Eur Urol 2026;1055-1060 doi.org/10.1016/j.euo.2026.07.014: A Mutation Is Not a Mechanism: Interpreting PROpel Gene by Gene
RE: Neal Shore, Noel W. Clarke, Andrew J Armstrong et al.Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel. Eur Urol 2026;1055-1060 doi.org/10.1016/j.euo.2026.07.014: A Mutation Is Not a Mechanism: Interpreting PROpel Gene by Gene. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126002592?dgcid=rss_sd_all
RE: Neal Shore, Noel W. Clarke, Andrew J Armstrong et al.Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel. Eur Urol 2026;1055-1060 doi.org/10.1016/j.euo.2026.07.014: A Mutation Is Not a Mechanism: Interpreting PROpel Gene by Gene. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126002592?dgcid=rss_sd_all
“RE: Neal Shore, Noel W. Clarke, Andrew J Armstrong et al.Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel. Eur Urol 2026;1055-1060 doi.org/10.1016/j.euo.2026.07.014: A Mutation Is Not a Mechanism: Interpreting PROpel Gene by Gene.” European Urology Oncology.
@article{article45595,
title = {RE: Neal Shore, Noel W. Clarke, Andrew J Armstrong et al.Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel. Eur Urol 2026;1055-1060 doi.org/10.1016/j.euo.2026.07.014: A Mutation Is Not a Mechanism: Interpreting PROpel Gene by Gene},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126002592?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...